Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Current utilisation of advanced techniques and technologies in palliative radiation therapy in Australia and New Zealand.

Journal of medical imaging and radiation oncology·2024

Same author

Adjuvant nodal field radiation in resected Stage III melanoma: A single-centre retrospective study in Christchurch, New Zealand.

Journal of medical imaging and radiation oncology·2022

Same author

Faculty of Radiation Oncology 2018 workforce census: the status of the radiation oncology workforce in New Zealand.

The New Zealand medical journal·2020

Same author

Long-term results from a series of patients managed with breast conservation surgery and hypofractionated radiotherapy in Christchurch: What is the recurrence rate and how do we detect recurrences.

Journal of medical imaging and radiation oncology·2020

Same author

Hypofractionation for clinically localized prostate cancer.

The Cochrane database of systematic reviews·2019

Same author

High-grade Glioma - A decade of care in Christchurch.

Journal of medical imaging and radiation oncology·2019

Same journal

Rheumatoid arthritis: previously untreated early disease.

BMJ clinical evidence·2016

Same journal

Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.

BMJ clinical evidence·2016

Same journal

Subarachnoid haemorrhage (spontaneous aneurysmal).

BMJ clinical evidence·2016

Same journal

Malaria: fluid therapy in severe disease.

BMJ clinical evidence·2016

Same journal

Age-related macular degeneration: anti-vascular endothelial growth factor treatment.

BMJ clinical evidence·2016

Same journal

MRSA: treating people with infection.

BMJ clinical evidence·2016

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate cancer (early).

Melissa L James¹

¹Christchurch Oncology Services, Christchurch Hospital, Christchurch, New Zealand.

BMJ Clinical Evidence

|May 21, 2009

Summary

This summary is machine-generated.

This review examines treatments for early prostate cancer, finding various options like surgery, radiation, and hormone therapy. It assesses their effectiveness and safety for men, particularly those over 65.

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: Jun 23, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Area of Science:

Oncology
Urology

Background:

Prostate cancer is a leading cancer globally, predominantly affecting men over 65.
Early-stage prostate cancer shows variable progression-free survival rates at 5 and 10 years.

Purpose of the Study:

To systematically review the effects of various treatments for early prostate cancer.
To evaluate the effectiveness and safety of different therapeutic interventions.

Main Methods:

Systematic review of 25 studies including systematic reviews, RCTs, and observational studies.
Searched major databases up to February 2006.
Included harms alerts from regulatory agencies (FDA, MHRA).

Main Results:

Evaluated evidence quality using GRADE methodology.
Assessed interventions including radical prostatectomy, radiation therapy (external beam, brachytherapy), and hormone therapy combinations.
Included watchful waiting as a management strategy.

Conclusions:

Presents comprehensive information on the effectiveness and safety of multiple early prostate cancer treatments.
Covers interventions such as radical prostatectomy, radiation therapy, hormone therapy, and watchful waiting.